A study of frontline therapy in adults >80 years with chronic lymphocytic leukemia (CLL)

被引：0
|
作者：
Tsang, Mazie
Hampel, Paul Joseph
Rabe, Kari G.
Ding, Wei
Leis, Jose Francisco
Kenderian, Saad
Wang, Yucai
Muchtar, Eli
Koehler, Amber
Hanson, Curtis A.
Shi, Min
Slager, Susan L.
Kay, Neil E.
Parikh, Sameer Ashok
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Clin Trials & Biostat, Rochester, MN USA
[4] Mayo Clin, Div Hematol, Rochester, MN USA
[5] Mayo Clin, Dept Lab & Oncol, Rochester, MN USA
[6] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12057
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A study of frontline therapy in adults aged 80+years with chronic lymphocytic leukemia (CLL)
    Tsang, Mazie
    Hampel, Paul
    Rabe, Kari
    Ding, Wei
    Leis, Jose
    Kenderian, Saad
    Wang, Yucai
    Muchtar, Eli
    Koehler, Amber
    Hanson, Curtis
    Shi, Min
    Slager, Susan
    Kay, Neil
    Parikh, Sameer
    LEUKEMIA & LYMPHOMA, 2023, 64 : S189 - S190
  • [2] FCR-3 as frontline therapy for patients with chronic lymphocytic leukemia (CLL).
    O'Brien, S
    Wierda, WG
    Faderl, S
    Ferrajoli, A
    Bueso-Ramos, CE
    Browning, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2005, 106 (11) : 599A - 599A
  • [3] Frontline therapy in Chronic Lymphocytic Leukemia
    Arguello-Tomas, Miguel
    Albiol, Nil
    Moreno, Carol
    ACTA HAEMATOLOGICA, 2024, 147 (01) : 49 - 61
  • [4] The GAIA (CLL13) trial: An international intergroup phase III study for frontline therapy in chronic lymphocytic leukemia (CLL).
    Julia, Von Tresckow
    Carsten, Niemann
    Kater, Arnon P.
    Bahlo, Jasmin
    Farstenau, Moritz
    Fink, Anna-Maria
    Gregor, Michael
    Thornton, Patrick
    Tadmor, Tamar
    Fischer, Kirsten
    Ritgen, Matthias
    Kreuzer, Karl A.
    Eldering, Eric
    Stilgenbauer, Stephan
    Van Oers, Marinus
    Geisler, Christian
    Hallek, Michael J.
    Eichhorst, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Treatment of chronic lymphocytic Leukemia in over 80 Years: Experience of the German CLL Study Group (GCLLSG)
    Goede, V.
    Engelke, A.
    Busch, R.
    Hallek, M.
    INTERNIST, 2013, 54 : 127 - 127
  • [6] FLUDARABINE PLUS THALIDOMIDE AS FRONTLINE THERAPY FOR NEWLY DIAGNOSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Ailawadhi, S.
    Miller, K. C.
    Depaolo, D.
    Whitworth, A.
    Brady, W.
    Czuczman, M.
    Bernstein, Z. P.
    Hernandez-Ilizaliturri, F.
    Padmanabhan, S.
    Chanan-Khan, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 34 - 34
  • [7] Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
    Erin M. Pettijohn
    Shuo Ma
    Current Hematologic Malignancy Reports, 2017, 12 : 20 - 28
  • [8] Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
    Pettijohn, Erin M.
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (01) : 20 - 28
  • [9] Risk of Hospitalizations Following Initiation of Frontline Therapy in Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
    Mato, Anthony
    Lin, Jennifer
    Deshmukh, Siddhant
    Wang, Song
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S300 - S301
  • [10] Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy
    Sara Small
    Shuo Ma
    Current Hematologic Malignancy Reports, 2021, 16 : 325 - 335
12345